Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Re: US JSGPM program

5 Oct 2007 07:00

Avon Rubber PLC05 October 2007 Strictly embargoed until Friday, 5 October 2007 Avon Rubber p.l.c. ("Avon" or "the Group") Full rate production decision on M50 Mask for US JSGPM program The Joint Program Executive Officer for Chemical and Biological Defence, hasapproved the Joint Service General Purpose Mask ("JSGPM") Program for entry intothe Full Rate Production Phase of Systems Acquisition. The collaboration betweenAvon and the Joint Project Manager for Individual Protection has resulted inthis significant milestone which will allow Avon's Cadillac, Michigan plant toramp up to full rate production to support fielding of this product to the U.S.Armed Forces. This milestone allows the U.S. Government to exercise the fullrate production portion of its contract with Avon and commence full rateproduction and fielding. The first multi year order is planned at a rate of100,000 masks per annum for an initial contract period of five years withadditional orders for both masks and spares to follow. It is anticipated thatorders in the first year will exceed $40 million. The development of the M50 Mask by Avon has resulted in the world's mostadvanced respiratory protection mask, offering huge improvements in comfort,usability and operational effectiveness, as well as protection. It will replacethe M40 mask which has been in service with the US military for more than 15years. The JSGPM program is likely to become the largest respiratory protectioncontract and will equip all five US armed forces. Avon has managed the complexand technologically demanding development of the M50 to meet the JSGPMrequirement since being awarded the original contract in 2000. The M50 and its extensive range of associated products including the uniqueconformal filters and advanced visor, will be manufactured at Avon's state ofthe art production facility in Cadillac, Michigan. Commenting on the full rate production of the M50, Terry Stead, Chief Executiveof Avon Rubber p.l.c., said: "This is a wonderful day for Avon and puts us ontrack to become the largest supplier of military CBRN respirators. It is theresult of over seven years of dedicated effort working with the US Department ofDefense and we are very proud of this achievement." - Ends - For further enquiries, please contact: Avon Rubber p.l.c. 01225 896831Terry Stead, Chief Executive 01225 896871Fiona Stewart (Local/Trade Press) Weber Shandwick FinancialRichard Hews / Rachel Martin / Hannah Marwood 020 7067 0700 NOTES TO EDITORS: Avon Rubber p.l.c. is an international polymer engineeringgroup adding value through material, manufacturing and industry sectorexpertise. The Group is currently capitalised at approximately £45 million. Avonsupplies a range of advanced CBRN respiratory protection solutions through AvonProtection Systems Inc. to the world's military and police forces, as well asfirst responders and emergency services. Avon Rubber p.l.c. owns Avon-ISI, whichdesigns, develops and manufactures a range of self-contained breathing apparatusfor fire, rescue and law enforcement, as well as military applications. AvonRubber p.l.c. also owns Avon Engineered Fabrications manufacturing productsincluding hovercraft skirting and flexible storage tanks, an aerosol gasketbusiness and a world leading dairy business manufacturing dairy liners andtubing. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.